Oncternal Therapeutics (ONCT) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan Oncternal Therapeutics, Inc. (ONCT)

Oncternal Therapeutics management is implementing advanced methods to combat resistant tumors, establishing new standards of care. The quarterly EPS change reflects the dynamics of this strategy, where the 14.30 level serves as a critical benchmark. Oncternal Therapeutics is developing robust R&D capabilities in molecular synthesis and targeted inhibitors. The business is currently focusing on clinical trials of ROR1 inhibitors for the therapy of lymphomas.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Oncternal Therapeutics, Inc. (ONCT): kanggo periode 04.07.2022 - 14.12.2024

Rincian analitis perusahaan Oncternal Therapeutics

Analisis fundamental perusahaan:oncternal.com, ONCT
Produk asil prodhuksi Oncternal Corp

Outsourcing the production of targeted lymphoma drugs minimizes capital expenditures for Oncternal Therapeutics (ONCT), directly impacting the bottom line. This trend captures the percentage change in quarterly earnings per share, allowing the quarterly EPS growth profile to reflect the efficiency of the operating model and the fundamental resilience of the business against industry risks.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|INBX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|HRTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Nuvectis Pharma, Inc.|CHRS: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Corbus Pharma CRBP|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CRDF|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BeyondSpring Inc. BYSI|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan CANF (Can-Fite BioPharma, Ltd.)|APRE: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Kazia (KZIA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan silexion.com|NCNA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CMRX|Wutah bathi EPS kuartalan Cyclacel, Inc. (CYCC)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|KTRA: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc